SEC Company Response from RELMADA THERAPEUTICS, INC. (RLMD) (CIK 0001553643) (RLMD) — Mar 19, 2013
RELMADA THERAPEUTICS, INC. (RLMD) (CIK 0001553643)
Date: March 19, 2013 · CIK: 0001553643 · Accession: 0001255294-13-000210
AI Filing Summary & Sentiment
File numbers found in text: 333-184881
Show Raw Text
CORRESP 1 filename1.htm Camp NINE, INC. March 18, 2013 THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION Attn: Susan Block Division of Corporation Finance Mail Stop 7010 100 F. Street NE Washington, D.C. 20549-7010 Re: Camp Nine, Inc. Registration Statement on Form S-1 File No. 333-184881 Dear Mrs. Block: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Camp Nine, Inc. (the “Company”) hereby requests acceleration of the effective date of its Registration Statement on Form S-1 to 4:00 PM Eastern Standard Time on March 22, 2013, or as soon thereafter as is practicable. The Company acknowledges the following: Should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing; The action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and The Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. Thank you for your assistance. Please call with any questions. CAMP NINE, INC. By: /s/ Michael Garcia Michael Garcia Chief Executive Officer 1065 Kawaiahao St Ste 2207, Honolulu, Hawaii 96814 Phone: (803) 226-7944